Cargando…
Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
The global spread of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has provoked an urgent need for prophylactic measures. Several innovative vaccine platforms have been introduced and billions of vaccine doses have been administered worldwi...
Autores principales: | Kim, Chulwoo, Kim, Jae-Deog, Seo, Sang-Uk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Microbiological Society of Korea
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795728/ https://www.ncbi.nlm.nih.gov/pubmed/35089583 http://dx.doi.org/10.1007/s12275-022-1608-z |
Ejemplares similares
-
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
por: Park, Jung-Eun, et al.
Publicado: (2022) -
Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
por: Perotti, Michela, et al.
Publicado: (2019) -
Construction of SARS-CoV-2 virus-like particles in plant
por: Moon, Ki-Beom, et al.
Publicado: (2022) -
A perspective on SARS-CoV-2 virus-like particles vaccines
por: Gao, Xiaoyang, et al.
Publicado: (2023) -
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses
por: Bommireddy, Ramireddy, et al.
Publicado: (2022)